Biogen boosts investment in neurology with $1 billion Ionis deal

(Reuters) - U.S. drugmaker Biogen Inc rolled out part of its $37 billion investment warchest on Friday, signing a $1 billion deal that seeks to expand on the strength of an existing partnership with Ionis Pharmaceuticals Inc.

Biogen boosts investment in neurology with $1 billion Ionis deal
Read More


Bagikan Berita Ini